USD10
SMMT Shares
About Summit TherapeuticsSummit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
USD10
SMMT Shares
About Summit TherapeuticsSummit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Stats
TRADING WINDOW
Closed
OPENS AT
Jul 6 at 1:30 PM GMT+0
MARKET CAP
$12.03B
OPEN PRICE
Not enough data
LOW (1Y)
$12.55
HIGH (1Y)
$30.98
LOW (24H)
$15.43
HIGH (24H)
$15.51
VOLUME (24H)
$3.52K
100%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $15.43 | |
1 Week | $14.25 | |
1 Month | $14.69 | |
1 Year | $22.61 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.